+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "RNA Therapy"

From
RNA Based Therapeutics Market 2024-2028 - Product Thumbnail Image

RNA Based Therapeutics Market 2024-2028

  • Report
  • August 2024
  • 208 Pages
  • Global
From
From
Ribose-Nucleic Acid (RNA)-based Therapeutics Market Report 2024 - Product Thumbnail Image

Ribose-Nucleic Acid (RNA)-based Therapeutics Market Report 2024

  • Report
  • October 2024
  • 175 Pages
  • Global
From
The Global Exosome Market: Size, Forecast, Trials, and Trends, 2024 - Product Thumbnail Image

The Global Exosome Market: Size, Forecast, Trials, and Trends, 2024

  • Report
  • September 2024
  • 351 Pages
  • Global
From
Gene Therapy R&D Market Report 2024-2034 - Product Thumbnail Image

Gene Therapy R&D Market Report 2024-2034

  • Report
  • May 2024
  • 340 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

RNA therapy is a form of gene therapy that uses RNA molecules to treat or prevent diseases. It is a type of genomics-based therapy that works by introducing genetic material into cells to modify their behavior. RNA therapy can be used to treat a variety of diseases, including cancer, neurological disorders, and infectious diseases. It has the potential to be used to treat genetic disorders, as well as to modify the expression of genes in order to improve the effectiveness of existing treatments. RNA therapy works by introducing genetic material into cells, which can then be used to modify the expression of genes. This can be done by introducing a gene that produces a therapeutic protein, or by introducing a gene that silences a gene that is causing a disease. RNA therapy can also be used to modify the expression of existing genes, which can be used to improve the effectiveness of existing treatments. RNA therapy is an emerging field of genomics-based therapy, and is being explored by a number of companies. Examples of companies in the RNA therapy market include Moderna, BioNTech, and Arcturus Therapeutics. Show Less Read more